TransAct Technologies IncorporatedTACTNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P29
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-3.96%
2024-26.11%
202310.18%
202214.65%
202131.07%
202029.82%
2019-4.00%
20186.34%
2017-2.76%
201622.95%